What makes up the gut microbiome?

Gut microbiota — at the intersection of everything? Patrice D. Cani, Nature Reviews Gastroenterology & Hepatology, 2017

Download this diagram

It is quite normal for the average gut to have a tremendous number of microbial consortia living symbiotically, specifically including 3

  • BACTERIA

  • YEASTS

  • VIRUSES

  • ARCHAEA

  • FUNGI

The gastrointestinal tract plays host to more than one thousand species of bacteria, which are actually beneficial. A gut that contains a diverse array of bacteria has been shown to be more stable and resilient to, for example, infection – so diversity of bacteria is known to be an indicator of a healthy gut. 4

However, research has demonstrated that the composition of the gut microbiome is not static, and can alter according to changes in diet 5, stress 6 or amount and quality of sleep. 7

Balancing the gut microbiome

The gut microbiome varies from person to person – each one not identical to any other. The precise quantities of different microbes is dependent on a number of circumstances, not all of which we are able to influence.

When a child is born, for example, the way they are delivered can have an impact on the transition of microbiota between mother and baby. If an unborn baby is exposed to antibiotics in the womb, then this too can have an impact on the make-up of their gut microbiome. 8

However, individuals do have control over the lifestyle choices they make, and this can have a significant impact in terms of maintaining the balance of their gut microbiome. By striving towards healthy practices – such as eating a nutritious, varied diet, or exercising frequently – individuals can thereby maximise the likelihood of achieving a healthy balance in their gut microbiome.9

What does the gut microbiome do in the body?

The gut microbiome plays a key role in a number of functions that help to sustain a healthy body:

Akkermansia muciniphila makes these byproducts available to the body and other gut bacteria – and because it supplies nutrients in this way, it can be considered a keystone species.

As well as being associated with good gut barrier function, using Akkermansia muciniphila as a food supplement in combination with a healthy and balanced diet has been shown to restore gut barrier function in obese mice. 5

Optimal Akkermansia muciniphila levels have a number of positive effects:

  • METABOLISM

  • Fermenting non-digestible food components (mainly dietary fibre) to produce short-chain fatty acids that help maintain a healthy colon10

  • Synthesising of essential nutrients, such as B vitamins.11

  • Release/stimulation of neurotransmitters, e.g. dopamine and serotonin.12

  • IMMUNITY

  • Gut-associated lymphoid tissue is highly specialised and is the main entity of mucosal-associated lymphoid tissue, representing ~70% of the entire immune system.

  • Gut microbiota help to direct the immune system in knowing when to tolerate and when to respond to potential threats.13

  • The gut microbiota acts as a structural barrier, preventing pathogen adhesion and subsequent colonisation. 13

    PROTECTION

REFERENCES

  1. Ursell LK, et al. Defining the human microbiome. Nutr Rev 2012;70(1):S38-S44.
  2. Bull MJ and Plummer NT. The human gut microbiome in health and disease. Integr Med 2014;13(6):17-22.
  3.  Sender R, et al. Revised estimates for the number of human and bacteria cells in the body. PLOS Biology 2016;14(8):e1002533.
  4. McBurney MI, et al. Establishing what constitutes a healthy human gut microbiome: state of the science, regulatory considerations, and future directions. J Nutrition 2019;149(11):1882-1895.
  5. So D, et al. Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. Am J Clin Nutrition 2018;107(6):965-983.
  6. Conlon MA and Bird AR. The impact of diet and lifestyle on gut microbiota and human health. Nutrients 2015;7(1):17-44.
  7. Benedict C, et al. Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals. Mol Metab 2016;5(12):1175-1186.
  8. Mueller NT, et al. The infant microbiome development: mom matters. Trends Mol Med 2015;21(2):109-117.
  9. Quigley E. Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet? Nat Rev Gastroenterol Hepatol 2017;14:315-320.
  10. Gill PA, et al. Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders. Aliment Pharmacol Ther 2018;48(1):15-34.
  11. Magnusdottir S, et al. Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes. Front Genet 2015;6:148.
  12. Cryan JF, et al. The microbiota-gut-brain axis. Physiol Rev 2019;99(4):1877-2013.
  13. Iacob S, et al. Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats. Front Microbiol 2018;9:3328.